Endocannabinoid System and Psychosis Risk: Clinical Evidence
Cannabis induced psychosis significantly increases the risk of developing schizophrenia spectrum and bipolar disorder. Clinical evidence highlights the need for careful diagnostic evaluation and monitoring. Early identification of cannabis induced…
Endocannabinoid System in First-Episode Psychosis Care
People with first-episode psychosis have elevated rates of criminal legal involvement that are measurable at baseline and predictable using identifiable clinical and demographic factors. Early identification of individuals at higher risk for legal…
Endocannabinoid System in Trauma: Clinical Research Evidence
Clinical research highlights the role of the endocannabinoid system trauma substance use connection in posttraumatic outcomes. Insomnia symptoms before trauma predict higher rates of alcohol and cannabis use. Understanding this link aids early…
Endocannabinoid System Research and Clinical Psychosis Care
Clinical psychosis care benefits from understanding the endocannabinoid system's role in first-episode psychosis. Research highlights predictors of legal involvement during early psychosis. This knowledge aids targeted interventions to improve patient…
Progression of Cannabis-Induced Psychosis to Schizophrenia and Bipolar Disorder
Cannabis induced psychosis schizophrenia bipolar progression is a critical clinical concern. Many patients with cannabis-induced psychosis later develop schizophrenia spectrum or bipolar disorder. Early identification and monitoring of this progression…
Where Teens Get Misused Prescription Drugs Shapes Their Risk Profile
Nonmedical prescription drug misuse adolescents show varied risk profiles based on how they obtain drugs. Teens using multiple sources face higher substance use involvement. Understanding these patterns helps target prevention and screening.
Endocannabinoid System & Cannabis-Induced Psychosis Research
Cannabis-induced psychosis schizophrenia risk is a critical concern for clinicians. A significant portion of patients with cannabis-induced psychosis later develop schizophrenia spectrum or bipolar disorder. Early identification and structured follow-up…